Position in MRK
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$8,036,390
+$480,254 QoQ
Shares Held
62,540
-0.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.35%
of 13F equity value
Holder Rank
#836
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Argyle Capital Management, LLC holds $43,679,401 across 8 Drug Manufacturers - General names. MRK ranks #2 (18.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,767 | $12,914,263 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
62,540 | $8,036,390 | |
| 3 | AMGN |
Amgen Inc
|
19,501 | $7,061,702 | |
| 4 | JNJ |
Johnson & Johnson
|
25,649 | $6,514,076 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
72,282 | $4,164,888 | |
| 6 | PFE |
Pfizer Inc
|
155,636 | $3,747,714 | |
| 7 | ABBV |
AbbVie Inc.
|
3,450 | $868,158 | |
| 8 | NVS |
Novartis AG
|
2,375 | $372,210 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,036,390 | 62,540 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $7,556,136 | 62,816 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $6,685,694 | 63,516 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $5,024,553 | 59,866 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $4,694,267 | 59,301 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $5,349,785 | 59,601 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $5,781,280 | 58,115 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $6,092,266 | 53,648 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $7,022,307 | 56,723 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $7,970,835 | 60,408 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $6,814,840 | 62,510 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $7,385,118 | 71,735 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $8,291,348 | 71,855 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $7,960,418 | 74,823 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $8,468,147 | 76,324 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $6,701,341 | 77,814 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $7,110,257 | 77,989 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $6,377,500 | 77,727 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $6,444,810 | 84,092 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $6,316,150 | 84,092 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $6,542,556 | 84,127 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $6,488,052 | 84,162 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $6,884,448 | 84,162 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $7,063,029 | 85,148 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $6,746,813 | 87,247 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $6,733,555 | 87,517 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||